Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Nanotechnology and COVID-19 convergence: toward new planetary health interventions against the pandemic

P Sahoo, J Dey, SR Mahapatra, A Ghosh… - OMICS: A Journal of …, 2022 - liebertpub.com
COVID-19 is a systemic disease affecting multiple organ systems and caused by infection
with the SARS-CoV-2 virus. Two years into the COVID-19 pandemic and after the …

A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples

Z Swank, G Michielin, HM Yip… - Proceedings of the …, 2021 - National Acad Sciences
Novel technologies are needed to facilitate large-scale detection of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) specific antibodies in human blood samples. Such …

Perceptions on undertaking regular asymptomatic self-testing for COVID-19 using lateral flow tests: a qualitative study of university students and staff

M Wanat, M Logan, JA Hirst, C Vicary, JJ Lee… - BMJ open, 2021 - bmjopen.bmj.com
Objectives Successful implementation of asymptomatic testing programmes using lateral
flow tests (LFTs) depends on several factors, including feasibility, acceptability and how …

[HTML][HTML] SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display

RA Ehling, CR Weber, DM Mason, S Friedensohn… - Cell reports, 2022 - cell.com
Characterization of COVID-19 antibodies has largely focused on memory B cells; however, it
is the antibody-secreting plasma cells that are directly responsible for the production of …

Designing of rapid assay for the detection of RdRp/Orf1ab specific to SARS-CoV-2

DÇ Derin, E Gültekin, Iİ Taşkın, B Otlu… - Journal of Virological …, 2023 - Elsevier
SARS-CoV-2 is still threat and mostly used detection method is real time reverse
transcriptase polymerase chain reaction (rRT-PCR) for the open reading frame (Orf1ab) …

[HTML][HTML] Comparison of diagnostic accuracy for eight SARS-CoV-2 serological assays

A Tešija Kuna, M Hanžek, I Vukasović… - Biochemia …, 2021 - hrcak.srce.hr
Comparison of diagnostic accuracy for eight SARS-CoV-2 serological assays Skoči na glavni
sadržaj english Prijava i registracija Prijava Promjena načina autentikacije Registracija srce …

Feasibility and acceptability of community coronavirus disease 2019 testing strategies (FACTS) in a university setting

JA Hirst, M Logan, TR Fanshawe… - Open forum …, 2021 - academic.oup.com
Background During the coronavirus disease 2019 (COVID-19) pandemic in 2020, the UK
government began a mass severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Prevalence of immunoglobulin G (IgG) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and evaluation of a rapid MEDsan IgG test in children …

KM Posfay-Barbe, DO Andrey, J Virzi… - Clinical Infectious …, 2021 - academic.oup.com
In 208 children seeking medical care, the seropositivity rate of anti–SARS-CoV-2 IgG
antibodies was 8.7%, suggesting an infection rate similar to that observed in adults but> 100 …

Serological and Molecular Tests for COVID-19: a recent update

AH Mansourabadi, M Sadeghalvad… - Iranian Journal of …, 2021 - iji.sums.ac.ir
The COVID-19 pandemic is probably the most devastating worldwide challenge in recent
century. COVID-19 leads to a mild to severe respiratory disease and affects different organs …